Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer

Clinical trial NCT00123851 · COMPLETED

Trial details

NCT number: NCT00123851
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Neoplasm Metastasis

Start date: 2003-03-01
Primary completion: 2006-08-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.